Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06157541
Status:
RECRUITING
Last Update Posted:
2024-05-31
First Post:
2023-11-26
Brief Title:
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
Sponsor:
Organization:
Queensland Institute of Medical Research